122 related articles for article (PubMed ID: 29023786)
1. Response to flecainide test in Andersen-Tawil syndrome with incessant ventricular tachycardia.
Fernández M; Marín MDR; Fernández-Armenta J; Mora-López F; Fernández Rivero R; Berruezo A; Cano Calabria L; Vázquez García R
Pacing Clin Electrophysiol; 2018 Apr; 41(4):429-432. PubMed ID: 29023786
[No Abstract] [Full Text] [Related]
2. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.
Sato A; Takano T; Chinushi M; Minamino T
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31311787
[TBL] [Abstract][Full Text] [Related]
4. Effect of flecainide on T-wave alternans in Andersen-Tawil syndrome.
Hayashi H; Kawaguchi T; Horie M
Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):383-6. PubMed ID: 25040481
[No Abstract] [Full Text] [Related]
5. Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome.
Erdogan O; Aksoy A; Turgut N; Durusoy E; Samsa M; Altun A
J Electrocardiol; 2008; 41(4):325-8. PubMed ID: 18353348
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome.
Maffè S; Paffoni P; Bergamasco L; Dellavesa P; Zenone F; Baduena L; Franchetti Pardo N; Careri G; Facchini E; Sansone V; Parravicini U
J Electrocardiol; 2020; 58():37-42. PubMed ID: 31710873
[TBL] [Abstract][Full Text] [Related]
9. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
[No Abstract] [Full Text] [Related]
10. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
[TBL] [Abstract][Full Text] [Related]
11. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
Ergül Y; Özgür S; Onan SH; Tuzcu V
Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.
Rujirachun P; Junyavoraluk A; Pithukpakorn M; Suktitipat B; Winijkul A
Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12798. PubMed ID: 32959505
[TBL] [Abstract][Full Text] [Related]
13. Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome.
Fox DJ; Klein GJ; Hahn A; Skanes AC; Gula LJ; Yee RK; Subbiah RN; Krahn AD
Europace; 2008 Aug; 10(8):1006-8. PubMed ID: 18621769
[TBL] [Abstract][Full Text] [Related]
14. Failure of radiofrequency catheter ablation and success of flecainide to suppress premature ventricular contractions in Andersen-Tawil syndrome: A case report.
Yilmaz S; Kanat S
J Electrocardiol; 2021; 68():37-40. PubMed ID: 34311212
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of Na⁺ and Ca²⁺ channels: a novel paradigm for the treatment of incessant ventricular arrhythmias in Andersen-Tawil syndrome.
Janson CM; Poelzing S; Shah MJ
Heart Rhythm; 2014 Feb; 11(2):318-20. PubMed ID: 24211314
[No Abstract] [Full Text] [Related]
16. Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT).
Tully I; Atherton J; Hunt L; Ingles J; Semsarian C; McGaughran J
Int J Cardiol; 2015 Dec; 201():473-5. PubMed ID: 26322597
[No Abstract] [Full Text] [Related]
17. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome.
Sumitomo N; Shimizu W; Taniguchi K; Hiraoka M
Heart Rhythm; 2008 Mar; 5(3):498-9. PubMed ID: 18313615
[No Abstract] [Full Text] [Related]
18. Transplacental flecainide therapy in the treatment of fetal supraventricular tachycardia.
D'Souza D; MacKenzie WE; Martin WL
J Obstet Gynaecol; 2002 May; 22(3):320-2. PubMed ID: 12521516
[No Abstract] [Full Text] [Related]
19. Combined flecainide and sotalol therapy for multifocal atrial tachycardia in cardio-facio-cutaneous syndrome.
Sakurai K; Takahashi K; Nakayashiro M
Pediatr Int; 2018 Nov; 60(11):1036-1037. PubMed ID: 30536490
[No Abstract] [Full Text] [Related]
20. Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.
Bigelow AM; Khalifa MM; Clark JM
Heart Rhythm; 2015 Jul; 12(7):1654-7. PubMed ID: 25814423
[No Abstract] [Full Text] [Related]
[Next] [New Search]